Health and Healthcare

Merck : MRK

All Merck Articles

1084 Articles

Chris Lange | Jan 25, 2016 at 11:35 AM EST

Could This Merck Deal Be the Turning Point for Affimed?

Affimed shares rose on Monday following the announcement of a collaboration in immuno-oncology with biotech giant Merck.

Jon C. Ogg | Jan 20, 2016 at 7:50 AM EST

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if…

Jon C. Ogg | Jan 13, 2016 at 10:35 AM EST

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

A bull market interrupted is how many investors likely feel at the start of 2016. These are the seven Dow…

Chris Lange | Jan 13, 2016 at 9:15 AM EST

Major Pharma Short Sellers Increase Bets

The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks…

Lee Jackson | Jan 8, 2016 at 11:05 AM EST

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

One good plan for stockholders who are seeing gains evaporate is to rotate to a more defensive sector. Large cap…

Chris Lange | Jan 6, 2016 at 10:35 AM EST

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case…

Jon C. Ogg | Jan 4, 2016 at 8:50 AM EST

Meet the Full 2016 Dogs of the Dow for Massive Dividends

Dogs of the Dow is a dividend strategy for investors to buy what are either "cheap" or "beaten up" Dow…

Lee Jackson | Dec 28, 2015 at 10:10 AM EST

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

These companies all provide drugs and medical devices that help hundreds of thousands of people daily lead a better life.…

Chris Lange | Dec 28, 2015 at 9:35 AM EST

Major Pharma Short Interest Takes Another Giant Leap Forward

The short interest data have been released for the December 15 settlement date, and for most of the selected pharmaceutical…

Paul Ausick | Dec 17, 2015 at 4:01 PM EST

The 4 Stocks That Sank the DJIA on Thursday

December 17, 2015: Markets opened higher on Thursday but the end came quickly for the gains. After about half an…

Jon C. Ogg | Dec 15, 2015 at 4:52 PM EST

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

Amgen is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a…

Paul Ausick | Dec 10, 2015 at 4:01 PM EST

The 4 Stocks That Lifted the Dow on Thursday

December 10, 2015: Markets opened lower for a fourth consecutive day on Thursday but almost immediately broke into positive territory…

Chris Lange | Dec 10, 2015 at 8:50 AM EST

Short Interest in Major Pharma Takes a Giant Leap

The November 30 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Dec 3, 2015 at 4:01 PM EST

The 4 Stocks That Tanked the DJIA on Thursday

December 3, 2015: Markets opened slightly higher on Thursday but any inference that equities were in for a good day…

Paul Ausick | Dec 1, 2015 at 4:01 PM EST

The 4 Stocks That Lifted the Dow on Tuesday

December 1, 2015: Markets opened higher on again on Tuesday and, unlike yesterday, held on to the gains for the…

1 … 38 39 40 41 42 … 73

Merck : MRK

All Merck Articles

Could This Merck Deal Be the Turning Point for Affimed?

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

Major Pharma Short Sellers Increase Bets

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

Meet the Full 2016 Dogs of the Dow for Massive Dividends

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

Major Pharma Short Interest Takes Another Giant Leap Forward

The 4 Stocks That Sank the DJIA on Thursday

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

The 4 Stocks That Lifted the Dow on Thursday

Short Interest in Major Pharma Takes a Giant Leap

The 4 Stocks That Tanked the DJIA on Thursday

The 4 Stocks That Lifted the Dow on Tuesday

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Merck : MRK

All Merck Articles

Could This Merck Deal Be the Turning Point for Affimed?

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

The DJIA Bullish Case of 19,700 in 2016: Apple, Boeing, IBM, Nike, Pfizer, Goldman Sachs and More

Major Pharma Short Sellers Increase Bets

Merrill Lynch Has 4 Safe Dividend-Paying Mega-Cap Pharmaceutical Stocks to Buy

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

Meet the Full 2016 Dogs of the Dow for Massive Dividends

Merrill Lynch Has 4 Large Cap Pharmaceutical Dividend Stocks for 2016

Major Pharma Short Interest Takes Another Giant Leap Forward

The 4 Stocks That Sank the DJIA on Thursday

How Amgen’s Larger-Than-Expected Dividend Hike Stacks Up to Peers

The 4 Stocks That Lifted the Dow on Thursday

Short Interest in Major Pharma Takes a Giant Leap

The 4 Stocks That Tanked the DJIA on Thursday

The 4 Stocks That Lifted the Dow on Tuesday

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Featured Reads

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It